Ashok Leyland, BDL, Alkem Headline Q4 Results on Eid-Closed Day

India’s stock exchanges sit dark on Thursday for Bakri Eid, but the country’s quarterly-results pile is doing the opposite. More than 470 listed companies are scheduled to file March-quarter and full-year FY26 results with the BSE on May 28, including Ashok Leyland, Bharat Dynamics, Alkem Laboratories, ITI, Tenneco Clean Air India and Prime Focus. The audited results land on the exchange portals through a session in which neither the BSE nor the NSE will trade equities. The first market reaction starts at Friday’s open.

The optics of a quiet tape understate what today’s slate is carrying. Four distinct sector reads sit inside the filings: the commercial-vehicle cycle through Ashok Leyland, the defense-order-book trajectory through Bharat Dynamics, the pharma pricing print through Alkem, and a cluster of niche-cap tests in telecom equipment, auto emissions hardware and post-production VFX.

Earnings Day Lands on a Closed Tape

Bakri Eid closes the BSE and NSE for the whole equity session on Thursday, with currency derivatives, the equity futures and options segment, the securities lending and borrowing book, and electronic gold receipts all suspended. The Multi Commodity Exchange of India runs only its evening half. Cash equities resume on Friday, May 29, per the NSE 2026 holiday calendar.

That puts the FY26 prints on the exchange portal as static filings rather than into a live tape. Pricing happens at Friday’s pre-open call auction starting 9:00 AM IST, with opening prints set across the entire pipeline before continuous trading begins fifteen minutes later.

For sell-side analysts the holiday is a workload compression. Conference dial-ins are booked across both days to spread the load. Ashok Leyland’s investor call is scheduled for 3:30 PM IST today. Alkem’s runs from 4:30 to 5:30 PM IST, hosted by Motilal Oswal Securities. Tenneco Clean Air India’s call has moved to 4:00 PM on Friday, after the cash market reopens.

The pattern of results into a closed tape is familiar in India. The last comparable instance was Republic Day in late January, when roughly seventy Q3 names filed into a shut market and the Friday after delivered wider opening ranges than the average session. Today’s pile is more than six times that size.

Ashok Leyland Sets the Commercial Vehicle Bar

Ashok Leyland is the day’s headline read on the commercial-vehicle cycle, and brokerage estimates point to a sequential softening rather than a beat. Street consensus puts standalone revenue in the ₹10,800 to ₹11,400 crore range (about $1.30 to $1.37 billion) and standalone profit at ₹530 to ₹600 crore. Both ranges sit modestly below the company’s record Q3, when freight demand and the GST-led price reset drove the highest quarterly volumes in its history.

The Q3 Baseline

The base is hard to lap. Consolidated revenue in the December quarter climbed 21.7% year-on-year to ₹11,534 crore, EBITDA jumped 26.7% to ₹1,535 crore, and the EBITDA (earnings before interest, taxes, depreciation and amortisation) margin expanded 53 basis points to 13.31%. Consolidated net profit was ₹862 crore, growing 5.19% over the same quarter a year earlier.

Market-share data inside the Q3 disclosure backed the volume story. The company held 30.9% of the medium and heavy commercial vehicle (MHCV) market and 12.1% of the light commercial vehicle (LCV) market, gaining ground in both. Domestic MHCV and LCV volumes grew 23.4% and 30% respectively.

What the Street Is Pricing for Q4

For Q4, the read is whether margin discipline holds even as the volume tailwind matures. The Society of Indian Automobile Manufacturers’ January to March 2026 CV segment data shows industry MHCV growth in the high single digits and LCV growth in the low double digits, narrower than the December-quarter spread.

The table below frames the comparison.

Dividend and Debentures on the Same Agenda

The board agenda goes beyond the print. Directors will also consider a final dividend for FY26 and a non-convertible debenture issuance on private placement, both decisions that feed the post-result narrative as much as the headline numbers do.

Bharat Dynamics Carries the Akash Order Book Forward

Bharat Dynamics enters its FY26 print with the rare combination of a defense PSU that is both order-book-heavy and export-active. The company’s board meeting filing on the BSE set the result for May 28 with a final dividend recommendation alongside.

The shape of the year was set in Q2, when revenue surged 111% year-on-year to ₹1,147 crore on the back of a breakthrough Armenia order for the Akash Weapon System. That delivery cycle is what the Q4 number has to substantiate. The Q4 question is whether execution kept pace, or whether scheduling slipped some of the deliveries into FY27.

The deeper read is the order book itself. As of April 2025 it stood near ₹22,700 crore, and FY25 exports printed at over ₹1,200 crore, a 640% jump from the prior year. The Cabinet Committee on Security has cleared Akash exports to nine countries, and the Q4 disclosure will be the first chance to size that pipeline in firm orders rather than letters of intent.

A January contract win of ₹2,095 crore from the defense ministry, plus a separate ₹2,960 crore tranche disclosed earlier, are both expected to show up in the FY26 closing book. The size of any new exports added in the March quarter will move the multi-year revenue visibility line more than the Q4 headline does.

Margin direction matters too. Defense PSU operating margins tend to expand as production runs lengthen and indigenous content rises, but the Q2 mix was unusually export-heavy and may not repeat. Friday’s pre-open will price the order book before it prices the margin.

Alkem’s Margin Test Spans Domestic and US Books

Alkem comes into Q4 with two storylines that pulled the previous quarter in different directions. The December quarter showed revenue up 10.7% to ₹3,737 crore and profit after tax up just 1.6% to ₹636 crore, a margin compression that owed to domestic pricing pressure and a Minimum Import Price on penicillin G, amoxicillin and 6-aminopenicillanic acid (6-APA, a key generic-antibiotic intermediate) that management has guided will shave ₹80 to ₹100 crore from annual earnings. The full set sits in Alkem’s May 20 board meeting notice on the BSE.

The international book is where Q4 will either re-anchor the thesis or extend the concern. Q3 international revenue grew 26.6% to ₹1,216 crore, with US generic sales up 18.8% to ₹753 crore and non-US sales surging 41.6% to ₹462 crore. Sustaining that mix would offset domestic pricing softness; a slowdown would not.

The Occlutech transaction sits adjacent to the print. Alkem’s binding term sheet to acquire a majority stake in the Switzerland-based cardiac-implant maker marks the company’s first material medical-device push, and the conference call this evening is the venue where management will be asked to talk timeline, funding mix and expected integration cost.

The headline EBITDA margin to watch is 22.2%, the Q3 figure. Anything closer to 20% would re-rate the second-half pharma read on the Nifty Pharma index; anything closer to 23% argues that the MIP impact is being absorbed without a dent to operating leverage.

ITI, Tenneco and Prime Focus Run the Mid-Cap Slate

Below the day’s marquee names sit three mid-cap prints, each carrying a distinct test. None is large enough to move an index, but each is a clean read on a niche industry the headline indices do not capture cleanly.

• ITI Limited, the central-government-owned telecom equipment manufacturer, prints into a stretched loss trajectory. Q3 standalone net loss narrowed to ₹25.58 crore from ₹67.12 crore a year earlier, and Q3 standalone revenue came in at ₹514.65 crore. The Q4 question is whether BharatNet and defense-PSU orders pushed the company to a quarterly breakeven for the first time in several years, or whether working-capital drag kept the loss column populated.
• Tenneco Clean Air India, the emissions-systems maker recently listed on the main board, faces its first full-year print as a public company. Street estimates put Q4 revenue at ₹305 to ₹330 crore and PAT at ₹20 to ₹25 crore on margins of 7% to 8%. The read is whether Bharat Stage VI Phase 2 (BS6 P2, the latest emissions-content standard for Indian commercial vehicles) content per vehicle sustained as CV mix shifted toward smaller LCVs through March.
• Prime Focus, the post-production and visual-effects house, comes in with Street estimates of ₹585 to ₹630 crore in Q4 revenue and ₹24 to ₹30 crore in PAT after a December quarter that saw consolidated net profit collapse 94% quarter-on-quarter to ₹3.60 crore. Margin recovery to 4.5% to 5.5% from 4.0% in Q3 is what analysts want to see in the FY26 closer.

Other names on the calendar include Apar Industries, Finolex Cables, Schneider Electric Infrastructure, Deepak Fertilisers and Petrochemicals, and Graphite India. Across the slate, the dispersion of expected outcomes is wider than at any earnings day so far in the FY26 cycle.

Friday’s Tape Inherits a Sector-Specific Pile

Friday morning’s pre-open will sort today’s filings into reactions before continuous trade starts. Four signals sit inside the day’s clustered prints, each tied to a different sector mood.

• 13.31% Ashok Leyland’s Q3 EBITDA margin; the read is whether Q4 holds the line as freight pricing normalises.
• ₹22,700 crore Bharat Dynamics’ April 2025 order book; Q4 will refresh that number and clarify the Akash export pipeline.
• 22.2% Alkem’s Q3 EBITDA margin; defending it is the test of how much MIP pressure the company can absorb.
• 94% the QoQ collapse in Prime Focus’s Q3 net profit; the Q4 print is a recovery test for a high-beta mid cap.

The compressed reaction window matters. With analysts pricing all 470-plus filings on one open, the breadth of opening-range moves on Friday is likely to read as a Q4 sector survey in itself rather than as company-specific reactions. The auto-OEM and defense-PSU pairs are the names brokers will study first because that is where the day’s most distinct directional reads sit.

For retail investors, the day’s note is process. Audited filings appear on bseindia.com and nseindia.com as they hit; conference-call audio replays are typically posted on company investor-relations pages within forty-eight hours; Friday’s pre-open is the first venue where the cluster prices on a live screen.

At 9:00 AM IST on Friday, the call auction window will set opening prints across the cluster all at once. That fifteen-minute reset, more than any individual board’s announcement today, is when the FY26 reporting book effectively closes.

Disclaimer: This article is for informational purposes only and is not investment advice. Equity investments are subject to market risk; estimates, ranges and order-book figures quoted are sourced from public exchange filings and analyst notes accurate as of publication on May 28, 2026, and may change after results are formally announced. Please consult a SEBI-registered investment adviser before acting on any view expressed here.